Ticker

No recent analyst price targets found for RBGPF.

Latest News for RBGPF

Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter

UBS maintained its 'buy' rating on Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the consumer goods company behind brands including Dettol, Nurofen and Durex, on Friday but cut its price target by 5% to £74, arguing the market has yet to reward the group for an improved long-term earnings growth model. The note followed Thursday's results, in which Reckitt reported like-for-like (LFL) sales growth of…

Proactive Investors • Mar 6, 2026
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress

Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the maker of Dettol, Nurofen and Durex, said it looks forward "with confidence" after a year in which its core business grew faster than its own medium-term targets, and promised to sustain that momentum into 2026. The…

Proactive Investors • Mar 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for RBGPF.

No Senate trades found for RBGPF.

No House trades found for RBGPF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top